Profil News

Our expert

Dr. Lars Bochmann

Executive Director Marketing & Business Development

December 2, 2022

Recent Profil Publications on Biosimilar Insulins

PubMed Central, the free full-text archive of biomedical and life sciences journal literature at the U.S. National Institutes of Health’s National Library of Medicine (NIH/NLM) lists 163 publications

November 8, 2022

Free Live Online Seminar: Profil - the leading CRO for metabolic research

We are happy to announce that our successful series of scientific online seminars continues. On December 07th, 2022 at 6 PM CET we will air our next complimentary live online seminar. The session is

November 2, 2022

Insulin Infusion System Failure – What’s the matter with the infusion sets?

For patients with type 1 diabetes, continuous subcutaneous insulin infusion (CSII) is a common therapy and represents a concept that, when compared to therapy with multiple daily injections, is

September 29, 2022

SURMOUNT-1 demonstrates substantial weight loss with Tirzepatide

Aim of the study SURMOUNT-1 [1] evaluated the efficacy and safety of tirzepatide in adults with obesity or overweight without diabetes. Gewichtsverlust / Diäterfolg dank Pillen – Tabletten, Kapseln

September 28, 2022

Profil World - The clinical diabetes research newsletter - Sep 2022

Dear all, Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity. On-demand

August 25, 2022

What role does COVID-19 play in the pathogenesis of diabetes mellitus

Patients who suffer from type 1 or type 2 diabetes generally have a higher risk of a COVID-19 infection [1]. It therefore comes as no surprise that for patients with diabetes, the COVID-19 pandemic

August 22, 2022

Free Live Online Seminar: Ethnic Bridging in Drug Development

We are happy to announce that our successful series of scientific online seminars continues. On September 13th, 2022 at 9 AM CEST we will air our next complimentary live online seminar. The session

August 12, 2022

The Profil Science Report 2021 - "What Science Can Do"

The Corona pandemic has shown the importance of scientific evidence when it comes to building trust in newly developed drugs given to millions of people. It has also highlighted the importance of

July 19, 2022

Don't let clinical trial subject recruitment hold you back!

The path for the development of new drugs and medicinal products can have many roadblocks ahead. These difficulties, especially at the beginning of developing a new drug, can have drastic